The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Deford John A since 2008.
This trader's CIK number is 1403373.
At the time of last reporting, Deford John A was the Director of Maravai Lifesciences Holdings, Inc.. (stock ticker symbol MRVI).
Also see all insider trading activities at Maravai Lifesciences Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | MRVI | 17,500 | $100,625 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | BCR | 0 | $0 | 20,105 | $5,953,615 | 14,107 | $2,508,281 |
| 2016 | BCR | 0 | $0 | 27,218 | $5,834,450 | 23,811 | $3,514,725 |
| 2015 | BCR | 0 | $0 | 32,907 | $6,186,545 | 23,774 | $2,509,432 |
| 2014 | BCR | 0 | $0 | 30,383 | $4,133,368 | 27,242 | $2,320,959 |
| 2013 | BCR | 0 | $0 | 69,779 | $7,993,195 | 62,781 | $5,322,724 |
| 2012 | BCR | 0 | $0 | 6,666 | $636,338 | 0 | $0 |
| 2011 | BCR | 0 | $0 | 25,359 | $2,378,657 | 21,425 | $1,508,148 |
| 2010 | BCR | 0 | $0 | 2,484 | $211,338 | 0 | $0 |
| 2009 | BCR | 0 | $0 | 2,254 | $161,070 | 0 | $0 |
| 2008 | BCR | 0 | $0 | 12,500 | $1,188,150 | 12,500 | $549,337 |
1. Maravai Lifesciences Holdings, Inc. (MRVI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-12 | MRVI | Buy | 17,500 | 5.75 | 100,625 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-20 | BCR | Option Ex | 14,107 | 177.80 | 2,508,281 |
| 2017-12-20 | BCR | Sale | 14,107 | 333.78 | 4,708,592 |
| 2014-12-17 | BCR | Sale | 2,741 | 168.51 | 461,877 |
| 2017-02-14 | BCR | Sale | 2,788 | 240.51 | 670,553 |
| 2017-02-13 | BCR | Sale | 469 | 240.07 | 112,593 |
| 2016-12-09 | BCR | Option Ex | 3,292 | 186.43 | 613,711 |
| 2016-12-09 | BCR | Sale | 3,292 | 215.00 | 707,780 |
| 2016-12-12 | BCR | Option Ex | 12,591 | 134.31 | 1,691,059 |
| 2016-12-12 | BCR | Sale | 12,591 | 218.96 | 2,756,862 |
| 2016-09-06 | BCR | Sale | 7,928 | 221.30 | 1,754,450 |
| 2016-09-06 | BCR | Option Ex | 7,928 | 152.62 | 1,209,955 |
| 2016-02-09 | BCR | Sale | 3,407 | 180.62 | 615,358 |
| 2015-12-16 | BCR | Option Ex | 4,662 | 97.69 | 455,407 |
| 2015-12-16 | BCR | Sale | 4,662 | 190.00 | 885,780 |
| 2015-12-14 | BCR | Option Ex | 5,627 | 84.58 | 475,903 |
| 2015-12-14 | BCR | Sale | 5,627 | 184.00 | 1,035,368 |
| 2015-08-04 | BCR | Option Ex | 13,485 | 117.03 | 1,578,122 |
| 2015-08-04 | BCR | Sale | 13,485 | 197.99 | 2,669,908 |
| 2015-02-20 | BCR | Sale | 2,987 | 174.94 | 522,539 |
| 2015-02-17 | BCR | Sale | 6,146 | 174.58 | 1,072,950 |
| 2014-12-16 | BCR | Option Ex | 5,626 | 84.58 | 475,818 |
| 2014-12-16 | BCR | Sale | 5,626 | 167.63 | 943,069 |
| 2014-02-12 | BCR | Sale | 3,141 | 136.41 | 428,466 |
| 2014-02-04 | BCR | Sale | 21,616 | 127.77 | 2,761,833 |
| 2014-02-04 | BCR | Option Ex | 21,616 | 85.36 | 1,845,141 |
| 2013-12-12 | BCR | Sale | 2,792 | 133.99 | 374,086 |
| 2013-09-09 | BCR | Option Ex | 28,364 | 87.45 | 2,480,431 |
| 2013-09-09 | BCR | Sale | 28,364 | 117.99 | 3,346,725 |
| 2013-07-26 | BCR | Option Ex | 34,417 | 82.58 | 2,842,293 |
| 2013-07-26 | BCR | Sale | 34,417 | 111.89 | 3,850,918 |
| 2013-02-19 | BCR | Sale | 4,206 | 100.21 | 421,466 |
| 2012-08-16 | BCR | Sale | 2,043 | 98.32 | 200,869 |
| 2012-02-15 | BCR | Sale | 2,130 | 95.28 | 202,935 |
| 2012-02-03 | BCR | Sale | 2,493 | 93.28 | 232,534 |
| 2011-02-15 | BCR | Sale | 3,934 | 97.72 | 384,418 |
| 2011-02-03 | BCR | Option Ex | 21,425 | 70.39 | 1,508,148 |
| 2011-02-03 | BCR | Sale | 21,425 | 93.08 | 1,994,239 |
| 2010-04-27 | BCR | Sale | 2,484 | 85.08 | 211,338 |
| 2009-04-30 | BCR | Sale | 2,254 | 71.46 | 161,070 |
| 2008-02-06 | BCR | Option Ex | 12,500 | 43.95 | 549,337 |
| 2008-02-06 | BCR | Sale | 12,500 | 95.05 | 1,188,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deford John A (Director of Maravai Lifesciences Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.